Breast cancer can be classified into five subtypes based on gene expression profiling and immunohistochemical expression of estrogen receptor α (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): luminal A, luminal B, HER2, and basal- and normal-like [19–21]. This evidence concerns the gene ESR1 and breast carcinoma.